Plain-English translation of NCT07195682 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new drug called for people with advanced kidney cancer (specifically clear cell renal cell carcinoma). Researchers want to find the right dose and see if this medication works well when given by itself or combined with other cancer treatments. This is the first time the medication is being tested in humans.
Advanced kidney cancer is difficult to treat, and some patients stop responding to existing therapies. This trial is exploring whether this new treatment approach might help patients whose cancer has progressed despite prior treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will take the medication by mouth as part of one of several study groups—either the medication alone or combined with one or two other cancer drugs. You will visit the clinic regularly for blood tests, imaging scans, and check-ups to monitor how the medication is working and any side effects you experience. The study will last as long as the treatment is helping you and you are tolerating it well.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States